Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 79 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Potassium citrate-potassium bicarbonate prolonged release granules for treating cystinuria	Potassium citrate-potassium bicarbonate	Cystinuria	Endocrine Nutritional and Metabolic Disorders , Genetic Disorders , Nephrology	2022	View \| Download
Ranibizumab for proliferative and non-proliferative diabetic retinopathy	Ranibizumab (Lucentis Port Delivery System; Lucentis)	Diabetic retinopathy	Endocrine Nutritional and Metabolic Disorders , Ophthalmology	2018	View \| Download
Ranibizumab port delivery system for treating diabetic macular oedema	Ranibizumab (Lucentis Port Delivery System; Lucentis)	Diabetic macular oedema	Endocrine Nutritional and Metabolic Disorders , Ophthalmology	2022	View \| Download
Semaglutide for overweight individuals	ATB200/AT2221 , Semaglutide (Ozempic)	Obesity , Weight management	Endocrine Nutritional and Metabolic Disorders	2020	View \| Download
Semaglutide for treating obesity-related heart failure	Semaglutide (Ozempic)	Obesity-related heart failure	Cardiovascular System , Endocrine Nutritional and Metabolic Disorders	2022	View \| Download
Semaglutide for treating overweight and obesity	Semaglutide (Ozempic)	Obesity	Endocrine Nutritional and Metabolic Disorders	2022	View \| Download
Semaglutide for treating overweight and obesity in adolescents ages 12 to 17 years old	Semaglutide (Ozempic)	Obesity	Endocrine Nutritional and Metabolic Disorders	2022	View \| Download
Semaglutide for treating overweight or obesity with cardiovascular disease	Semaglutide (Ozempic)	Cardiovascular disease (CVD) , Obesity	Cardiovascular System , Endocrine Nutritional and Metabolic Disorders	2023	View \| Download
Semaglutide for treating peripheral arterial disease (PAD) and type 2 diabetes	Semaglutide (Ozempic)	Peripheral arterial disease (PAD) , Type 2 diabetes	Cardiovascular System , Endocrine Nutritional and Metabolic Disorders	2022	View \| Download
Setmelanotide for obesity in Bardet-Biedl syndrome and Alstrom syndrome	Setmelanotide (RM-493)	Hyperphagia , Obesity	Endocrine Nutritional and Metabolic Disorders , Gastroenterology , Genetic Disorders	2021	View \| Download